APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dutasteride Industry Growth and Trends Forecast to 2032

20 December 2025107 pages

Choose your research edition.

Industry ResearchDutasteride Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Dutasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dutasteride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dutasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dutasteride include GSK, Amneal Pharma, Apotex, Bionpharma, Breckenridge Pharmaceutical, Marksans Pharma, Rising Pharmaceuticals, Zydus and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dutasteride market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dutasteride market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dutasteride market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dutasteride.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dutasteride market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dutasteride Market by Company

GSK

Amneal Pharma

Apotex

Bionpharma

Breckenridge Pharmaceutical

Marksans Pharma

Rising Pharmaceuticals

Zydus

Mylan

Teva

Dutasteride Segment by Type

Type I

Type II

Dutasteride Segment by Application

Hospital

Drug Store

Dutasteride Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dutasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Type I Table 2. Major Company of Type II Table 3. Global Dutasteride Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dutasteride Sales by Type (2021-2026) & (W Units) Table 5. Global Dutasteride Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dutasteride Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dutasteride Sales Market Share in Value by Type (2021-2026) Table 8. Global Dutasteride Price by Type (2021-2026) & (US$/Unit) Table 9. Global Dutasteride Sales by Type (2027-2032) & (W Units) Table 10. Global Dutasteride Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dutasteride Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dutasteride Sales Market Share in Value by Type (2027-2032) Table 13. Global Dutasteride Price by Type (2027-2032) & (US$/Unit) Table 14. North America Dutasteride Sales by Type (2021-2026) & (W Units) Table 15. North America Dutasteride Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dutasteride Sales by Type (2021-2026) & (W Units) Table 17. Europe Dutasteride Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dutasteride Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Dutasteride Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dutasteride Sales by Type (2021-2026) & (W Units) Table 21. Latin America Dutasteride Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dutasteride Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Dutasteride Sales by Type (2021-2026) & (US$ Million) Table 24. Dutasteride Industry Trends Table 25. Dutasteride Industry Drivers Table 26. Dutasteride Industry Opportunities and Challenges Table 27. Dutasteride Industry Restraints Table 28. Global Dutasteride Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dutasteride Revenue Market Share by Company (2021-2026) Table 30. Global Dutasteride Sales by Company (2021-2026) & (W Units) Table 31. Global Dutasteride Sales Share by Company (2021-2026) Table 32. Global Dutasteride Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Dutasteride Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dutasteride Major Company Production Sites and Headquarters Table 35. Global Dutasteride Company, Product Type & Application Table 36. Global Dutasteride Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dutasteride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dutasteride Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dutasteride Sales by Region (2021-2026) & (W Units) Table 41. Global Dutasteride Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dutasteride Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dutasteride Sales Market Share in Value by Region (2021-2026) Table 44. Global Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Dutasteride Sales by Region (2027-2032) & (W Units) Table 46. Global Dutasteride Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dutasteride Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dutasteride Sales Market Share in Value by Region (2027-2032) Table 49. Global Dutasteride Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Dutasteride Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dutasteride Sales by Application (2021-2026) & (W Units) Table 52. Global Dutasteride Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dutasteride Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dutasteride Sales Market Share in Value by Application (2021-2026) Table 55. Global Dutasteride Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dutasteride Sales by Application (2027-2032) & (W Units) Table 57. Global Dutasteride Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dutasteride Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dutasteride Sales Market Share in Value by Application (2027-2032) Table 60. Global Dutasteride Price by Application (2027-2032) & (US$/Unit) Table 61. North America Dutasteride Sales by Application (2021-2026) & (W Units) Table 62. North America Dutasteride Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dutasteride Sales by Application (2021-2026) & (W Units) Table 64. Europe Dutasteride Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dutasteride Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Dutasteride Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dutasteride Sales by Application (2021-2026) & (W Units) Table 68. Latin America Dutasteride Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dutasteride Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Dutasteride Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Dutasteride Product Portfolio Table 75. GSK Recent Development Table 76. Amneal Pharma Company Information Table 77. Amneal Pharma Business Overview Table 78. Amneal Pharma Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Amneal Pharma Dutasteride Product Portfolio Table 80. Amneal Pharma Recent Development Table 81. Apotex Company Information Table 82. Apotex Business Overview Table 83. Apotex Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Apotex Dutasteride Product Portfolio Table 85. Apotex Recent Development Table 86. Bionpharma Company Information Table 87. Bionpharma Business Overview Table 88. Bionpharma Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bionpharma Dutasteride Product Portfolio Table 90. Bionpharma Recent Development Table 91. Breckenridge Pharmaceutical Company Information Table 92. Breckenridge Pharmaceutical Business Overview Table 93. Breckenridge Pharmaceutical Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Breckenridge Pharmaceutical Dutasteride Product Portfolio Table 95. Breckenridge Pharmaceutical Recent Development Table 96. Marksans Pharma Company Information Table 97. Marksans Pharma Business Overview Table 98. Marksans Pharma Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Marksans Pharma Dutasteride Product Portfolio Table 100. Marksans Pharma Recent Development Table 101. Rising Pharmaceuticals Company Information Table 102. Rising Pharmaceuticals Business Overview Table 103. Rising Pharmaceuticals Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Rising Pharmaceuticals Dutasteride Product Portfolio Table 105. Rising Pharmaceuticals Recent Development Table 106. Zydus Company Information Table 107. Zydus Business Overview Table 108. Zydus Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Zydus Dutasteride Product Portfolio Table 110. Zydus Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Mylan Dutasteride Product Portfolio Table 115. Mylan Recent Development Table 116. Teva Company Information Table 117. Teva Business Overview Table 118. Teva Dutasteride Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Teva Dutasteride Product Portfolio Table 120. Teva Recent Development Table 121. North America Dutasteride Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Dutasteride Sales by Country (2021-2026) & (W Units) Table 123. North America Dutasteride Sales Market Share by Country (2021-2026) Table 124. North America Dutasteride Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Dutasteride Sales Market Share Forecast by Country (2027-2032) Table 126. North America Dutasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Dutasteride Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Dutasteride Market Share by Country (2021-2026) Table 129. North America Dutasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Dutasteride Market Share Forecast by Country (2027-2032) Table 131. Europe Dutasteride Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Dutasteride Sales by Country (2021-2026) & (W Units) Table 133. Europe Dutasteride Sales Market Share by Country (2021-2026) Table 134. Europe Dutasteride Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Dutasteride Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Dutasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Dutasteride Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Dutasteride Market Share by Country (2021-2026) Table 139. Europe Dutasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Dutasteride Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Dutasteride Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Dutasteride Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Dutasteride Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Dutasteride Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Dutasteride Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Dutasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Dutasteride Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Dutasteride Market Share by Country (2021-2026) Table 149. Asia-Pacific Dutasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Dutasteride Market Share Forecast by Country (2027-2032) Table 151. Latin America Dutasteride Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Dutasteride Sales by Country (2021-2026) & (W Units) Table 153. Latin America Dutasteride Sales Market Share by Country (2021-2026) Table 154. Latin America Dutasteride Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Dutasteride Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Dutasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Dutasteride Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Dutasteride Market Share by Country (2021-2026) Table 159. Latin America Dutasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Dutasteride Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Dutasteride Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Dutasteride Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Dutasteride Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Dutasteride Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Dutasteride Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Dutasteride Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Dutasteride Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Dutasteride Market Share by Country (2021-2026) Table 169. Middle East and Africa Dutasteride Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Dutasteride Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Dutasteride Distributors List Table 174. Dutasteride Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Dutasteride Image Figure 2. Global Dutasteride Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dutasteride Market Size (2021-2032) & (US$ Million) Figure 4. Global Dutasteride Sales (2021-2032) & (W Units) Figure 5. Type I Image Figure 6. Global Type I Sales YoY Growth (2021-2032) & (W Units) Figure 7. Type II Image Figure 8. Global Type II Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Dutasteride Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dutasteride Market Share by Type 2025 VS 2032 Figure 11. North America Dutasteride Sales Market Share in Volume by Type in 2025 Figure 12. North America Dutasteride Sales Market Share in Value by Type in 2025 Figure 13. Europe Dutasteride Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dutasteride Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dutasteride Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dutasteride Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dutasteride Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dutasteride Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dutasteride Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dutasteride Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dutasteride Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (W Units) Figure 27. Global Dutasteride Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Dutasteride Market Share by Application 2025 VS 2032 Figure 29. North America Dutasteride Sales Market Share in Volume by Application in 2025 Figure 30. North America Dutasteride Sales Market Share in Value by Application in 2025 Figure 31. Europe Dutasteride Sales Market Share in Volume by Application in 2025 Figure 32. Europe Dutasteride Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Dutasteride Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Dutasteride Sales Market Share in Value by Application in 2025 Figure 35. Latin America Dutasteride Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Dutasteride Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Dutasteride Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Dutasteride Sales Market Share in Value by Application in 2025 Figure 39. North America Dutasteride Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 40. North America Dutasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Dutasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Dutasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Dutasteride Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. Europe Dutasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dutasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Dutasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Dutasteride Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Asia-Pacific Dutasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dutasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Dutasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Dutasteride Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Latin America Dutasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dutasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Dutasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Dutasteride Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Middle East and Africa Dutasteride Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dutasteride Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Dutasteride Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Dutasteride Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Dutasteride Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Type I
  • Type II
Applications
  • Hospital
  • Drug Store
Companies covered
  • GSK
  • Amneal Pharma
  • Apotex
  • Bionpharma
  • Breckenridge Pharmaceutical
  • Marksans Pharma
  • Rising Pharmaceuticals
  • Zydus
  • Mylan
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dutasteride Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dutasteride Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dutasteride Market by Type
  6. 1.3.1 Type I
  7. 1.3.2 Type II
  8. 1.4 Global Dutasteride Market Size by Type
  9. 1.4.1 Global Dutasteride Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dutasteride Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dutasteride Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dutasteride Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dutasteride Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dutasteride Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dutasteride Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dutasteride Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dutasteride Industry Trends
  2. 2.2 Dutasteride Industry Drivers
  3. 2.3 Dutasteride Industry Opportunities and Challenges
  4. 2.4 Dutasteride Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dutasteride Revenue (2021-2026)
  2. 3.2 Global Top Players by Dutasteride Sales (2021-2026)
  3. 3.3 Global Top Players by Dutasteride Price (2021-2026)
  4. 3.4 Global Dutasteride Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dutasteride Major Company Production Sites & Headquarters
  6. 3.6 Global Dutasteride Company, Product Type & Application
  7. 3.7 Global Dutasteride Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dutasteride Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dutasteride Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dutasteride Tier 1, Tier 2, and Tier 3
4 Dutasteride Regional Status and Outlook
  1. 4.1 Global Dutasteride Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dutasteride Historic Market Size by Region
  3. 4.2.1 Global Dutasteride Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dutasteride Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dutasteride Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dutasteride Forecasted Market Size by Region
  7. 4.3.1 Global Dutasteride Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dutasteride Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dutasteride Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dutasteride by Application
  1. 5.1 Dutasteride Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Dutasteride Market Size by Application
  5. 5.2.1 Global Dutasteride Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dutasteride Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dutasteride Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dutasteride Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dutasteride Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dutasteride Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dutasteride Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dutasteride Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Dutasteride Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Amneal Pharma
  8. 6.2.1 Amneal Pharma Company Information
  9. 6.2.2 Amneal Pharma Business Overview
  10. 6.2.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharma Dutasteride Product Portfolio
  12. 6.2.5 Amneal Pharma Recent Developments
  13. 6.3 Apotex
  14. 6.3.1 Apotex Company Information
  15. 6.3.2 Apotex Business Overview
  16. 6.3.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Apotex Dutasteride Product Portfolio
  18. 6.3.5 Apotex Recent Developments
  19. 6.4 Bionpharma
  20. 6.4.1 Bionpharma Company Information
  21. 6.4.2 Bionpharma Business Overview
  22. 6.4.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bionpharma Dutasteride Product Portfolio
  24. 6.4.5 Bionpharma Recent Developments
  25. 6.5 Breckenridge Pharmaceutical
  26. 6.5.1 Breckenridge Pharmaceutical Company Information
  27. 6.5.2 Breckenridge Pharmaceutical Business Overview
  28. 6.5.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
  30. 6.5.5 Breckenridge Pharmaceutical Recent Developments
  31. 6.6 Marksans Pharma
  32. 6.6.1 Marksans Pharma Company Information
  33. 6.6.2 Marksans Pharma Business Overview
  34. 6.6.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Marksans Pharma Dutasteride Product Portfolio
  36. 6.6.5 Marksans Pharma Recent Developments
  37. 6.7 Rising Pharmaceuticals
  38. 6.7.1 Rising Pharmaceuticals Company Information
  39. 6.7.2 Rising Pharmaceuticals Business Overview
  40. 6.7.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Rising Pharmaceuticals Dutasteride Product Portfolio
  42. 6.7.5 Rising Pharmaceuticals Recent Developments
  43. 6.8 Zydus
  44. 6.8.1 Zydus Company Information
  45. 6.8.2 Zydus Business Overview
  46. 6.8.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Dutasteride Product Portfolio
  48. 6.8.5 Zydus Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Dutasteride Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Teva
  56. 6.10.1 Teva Company Information
  57. 6.10.2 Teva Business Overview
  58. 6.10.3 Teva Dutasteride Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Dutasteride Product Portfolio
  60. 6.10.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Dutasteride Sales by Country
  2. 7.1.1 North America Dutasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dutasteride Sales by Country (2021-2026)
  4. 7.1.3 North America Dutasteride Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dutasteride Market Size by Country
  6. 7.2.1 North America Dutasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dutasteride Market Size by Country (2021-2026)
  8. 7.2.3 North America Dutasteride Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dutasteride Sales by Country
  2. 8.1.1 Europe Dutasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dutasteride Sales by Country (2021-2026)
  4. 8.1.3 Europe Dutasteride Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dutasteride Market Size by Country
  6. 8.2.1 Europe Dutasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dutasteride Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dutasteride Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dutasteride Sales by Country
  2. 9.1.1 Asia-Pacific Dutasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dutasteride Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dutasteride Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dutasteride Market Size by Country
  6. 9.2.1 Asia-Pacific Dutasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dutasteride Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dutasteride Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dutasteride Sales by Country
  2. 10.1.1 South America Dutasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dutasteride Sales by Country (2021-2026)
  4. 10.1.3 South America Dutasteride Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dutasteride Market Size by Country
  6. 10.2.1 South America Dutasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dutasteride Market Size by Country (2021-2026)
  8. 10.2.3 South America Dutasteride Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dutasteride Sales by Country
  2. 11.1.1 Middle East and Africa Dutasteride Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dutasteride Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dutasteride Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dutasteride Market Size by Country
  6. 11.2.1 Middle East and Africa Dutasteride Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dutasteride Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dutasteride Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dutasteride Value Chain Analysis
  2. 12.1.1 Dutasteride Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dutasteride Production Mode & Process
  7. 12.2 Dutasteride Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dutasteride Distributors
  10. 12.2.3 Dutasteride Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst